SCHEMBL985048

SCHEMBL985048

COCCNc1cc(C(=O)Nc2ccccc2-c2nc3ccncc3s2)nc(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
MAPT P10636 3/20 0.45
RXFP1 Q9HBX9 1/20 0.45
TP53 P04637 3/20 0.44
LMNA P02545 1/20 0.41
ALDH1A1 P00352 2/20 0.41
P2RY12 Q9H244 1/20 0.40
NOX1 Q9Y5S8 1/20 0.39
TSHR P16473 2/20 0.39
USP2 O75604 1/20 0.39
MAPK1 P28482 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALOX15 P16050 1/20 0.39
DYRK1A Q13627 2/20 0.39
LIPG Q9Y5X9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12923330 0.87 HPGD (0.49) HPGDMAPTRXFP1TP53ALDH1A1
Hydrochloric Acid SCHEMBL981437 0.86 HPGD (0.49) HPGDMAPTRXFP1TP53ALDH1A1
SCHEMBL12923334 0.86 HPGD (0.45) HPGDMAPTRXFP1TP53ALDH1A1
SCHEMBL12923327 0.85 HPGD (0.52) HPGDMAPTRXFP1TP53ALDH1A1
SCHEMBL12923337 0.85 HPGD (0.47) HPGDMAPTRXFP1ALDH1A1TSHR
Hydrochloric Acid SCHEMBL984560 0.85 HPGD (0.51) HPGDMAPTRXFP1TP53ALDH1A1
SCHEMBL985220 0.85 MAPT (0.48) HPGDMAPTRXFP1TP53LMNA
Hydrochloric Acid SCHEMBL987012 0.84 HPGD (0.47) HPGDMAPTRXFP1ALDH1A1TSHR
SCHEMBL12923320 0.84 HPGD (0.47) HPGDMAPTRXFP1TP53LMNA
SCHEMBL12923325 0.84 P2RY12 (0.47) HPGDMAPTLMNAALDH1A1P2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTIS PHARMACEUTICALS, INC. (US) 2011-01-13 US disclosed
WO-2009061453-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRTRIS PHARMACEUTICALS, INC. (US) 2009-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009381-A1 SOLUBILIZED THIAZOLOPYRIDINES SIRT3, SIRT1, SIRT2 HPGD 230/4885MAPT 550/4885RXFP1 721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.